Discover how emerging evidence is reshaping the care of patients with aortic stenosis through earlier intervention, equitable access, and innovative digital technologies. This session will provide practical strategies to identify appropriate candidates for TAVR, address disparities in care, and leverage AI-enabled tools to enhance clinical decision-making and improve patient outcomes.
Learning Objectives
Learning Objectives:
- Compare traditional treatment with updated diagnostic criteria and risk stratification tools that support early transcatheter aortic valve replacement (TAVR) in asymptomatic patients, including interpretation of echocardiographic and biomarker findings.
- Examine the structural and systemic barriers contributing to delayed diagnosis and reduced access to TAVR in women, and apply strategies to advocate for equitable care.
- Evaluate the use of emerging digital technologies—such as AI-assisted echocardiography interpretation, remote patient monitoring, shared decision-making tools, and predictive analytics—to support earlier detection, risk assessment, and post-TAVR care coordination in patients with aortic stenosis.
CE certificate available upon successful completion of the post-test and program evaluation.
MS, NP
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.
